Acuta Capital Partners’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-290,000
| Closed | -$3.03M | – | 39 |
|
|
2022
Q3 | $3.03M | Buy |
+290,000
| New | +$3.03M | 1.3% | 20 |
|
|
2019
Q4 | – | Sell |
-140,000
| Closed | -$1.12M | – | 40 |
|
|
2019
Q3 | $1.12M | Sell |
140,000
-210,000
| -60% | -$1.68M | 0.81% | 26 |
|
|
2019
Q2 | $4.37M | Buy |
+350,000
| New | +$4.37M | 1.55% | 21 |
|
|
2018
Q1 | – | Sell |
-43,900
| Closed | -$632K | – | 45 |
|
|
2017
Q4 | $632K | Sell |
43,900
-256,100
| -85% | -$3.69M | 0.12% | 29 |
|
|
2017
Q3 | $4.52M | Buy |
+300,000
| New | +$4.52M | 0.81% | 20 |
|
|
2017
Q1 | – | Sell |
-145,300
| Closed | -$722K | – | 46 |
|
|
2016
Q4 | $722K | Sell |
145,300
-524,700
| -78% | -$2.61M | 0.27% | 32 |
|
|
2016
Q3 | $4.96M | Sell |
670,000
-491,545
| -42% | -$3.64M | 1.86% | 19 |
|
|
2016
Q2 | $6.34M | Sell |
1,161,545
-1,338,455
| -54% | -$7.31M | 3.05% | 9 |
|
|
2016
Q1 | $21.1M | Buy |
2,500,000
+997,339
| +66% | +$8.43M | 11.81% | 1 |
|
|
2015
Q4 | $14.6M | Buy |
1,502,661
+97,994
| +7% | +$951K | 6.97% | 3 |
|
|
2015
Q3 | $19.7M | Sell |
1,404,667
-370,333
| -21% | -$5.18M | 11.38% | 1 |
|
|
2015
Q2 | $25.1M | Sell |
1,775,000
-189,565
| -10% | -$2.68M | 15.53% | 1 |
|
|
2015
Q1 | $21.4M | Buy |
1,964,565
+331,845
| +20% | +$3.61M | 18% | 1 |
|
|
2014
Q4 | $13.6M | Buy |
+1,632,720
| New | +$13.6M | 9.18% | 1 |
|